ARCHIVES

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

DCT’s Experimental Therapeutic Program Outlined to Board

May 2, 1975

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010

“Mind Boggling” Results Reported In Trials Using 3-Drug Combination For Breast Cancer

October 10, 1975

Fisher Address Gap Between Clinicians Investigators, A Threat To Patient Welfare

May 28, 1993

Clinical Trials: NCI Forms Panel To Help Implement Recommendations

December 12, 1997

Patient Care Emerges as Major Concern Following Sequestration Cuts to Medicare

April 5, 2013